Individual-level Structural Neuroimaging Biomarkers across the Psychosis Spectrum
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background and Hypothesis
Although psychotic disorders are characterized by widespread cortical thinning, translating these findings into individualized biomarkers remains challenging. Regional Vulnerability Index (RVI) and Neuroscore are candidate individual-level biomarkers that quantify the similarity between an individual’s structural brain pattern and generic psychosis-associated alterations. This study investigated cortical thickness (CT)-based RVI and Neuroscore, along with mean CT deviation from healthy individuals, across the psychosis spectrum.
Study Design
Using structural 3T MRI data from 289 participants (clinical high risk for psychosis [CHR], n=39; first episode psychosis [FEP], n=44, chronic psychosis [CP], n=86; healthy controls [HC], n=120), RVI, Neuroscore, and mean CT deviation (z) scores were computed from region-wise CT measures quantified using FreeSurfer v7.2. Group differences and associations with symptoms were evaluated.
Study Results
RVI and Neuroscore were significantly higher, and mean CT z-scores lower, in FEP and CP compared with CHR and HC, with moderate-to-large effect sizes (|Cohen’s d| = 0.55–1.15). No differences were observed between FEP and CP or CHR and HC. Indices were not associated with psychosis-spectrum symptom severity in the CHR, FEP, or CP groups. RVI ( r = −0.561, p < .001) and Neuroscore ( r = −0.997, p < .001) were strongly negatively correlated with the mean CT z-score.
Conclusions
CT-based RVI and Neuroscore appear to index established disease status but not risk status, while showing substantial overlap with mean CT deviation. These findings highlight the need to further refine these biomarkers through data-driven and multimodal approaches to improve their utility for risk and prognostic prediction.
